Mosa Safi/LinkedIn
May 21, 2026, 13:08
Mosa Safi: Updated TXA Recommendations in Tactical Combat Casualty Care
Mosa Safi, Senior Medical Instructor at Prometheus Medical International, shared a post on LinkedIn:
“Tranexamic Acid (TXA) is now given as a single 2 g slow IV/IO push, replacing the older protocol of 1 g over 10 min and 1 g infusion over 8 hrs.
Current TCCC indications
Give TXA ASAP (within 3 hours of injury) if casualty has:
- Hemorrhagic shock / expected major transfusion
- Major amputation
- Penetrating torso trauma
- Severe bleeding
- Significant TBI or altered mental status after blunt/blast trauma.
Current TCCC Dose
TXA 2 g IV/IO slow push (single dose)
Why the change?
- Simplifies care in austere/combat settings
- Reduces missed second doses
- Emerging evidence suggests potential benefit in severe TBI
- Less cognitive load during prolonged evacuation
Important
Benefit decreases with delayed administration.
After more than 3 hours, TXA may lose benefit and potentially increase harm in bleeding trauma.
Teaching pearl
‘Early TXA matters more than perfect TXA dosing.’
Bottom line
- TCCC moved from 1 g and 1 g infusion – single 2 g TXA dose
- Include severe TBI among TXA indications
- Administer as early as possible and within 3 hours of injury.”

Stay updated with Hemostasis Today.
-
Jul 8, 2026, 05:53Excellent PhD Defense by Roberta Cirsmaru on Gene Therapy for Hemophilia A – CRH French Reference Center for Hemophilia Lyon
-
Jul 8, 2026, 05:48Riccardo Menandro: How Lipid Nanoparticles Are Shaping the Future of Rare Disease and Hemophilia Treatment
-
Jul 8, 2026, 05:39Daniel Victor Ortigoza: New Evidence from ATLANTIS-4D-CT on Apixaban and Subclinical Valve Thrombosis
-
Jul 8, 2026, 04:50Reza Bavarsad Shahripour: New AHA Guidance on Cryptogenic Stroke with Reduced Left Ventricular Function
-
Jul 7, 2026, 23:20Balaji Balagani: Exploring Pulmonary Embolism
-
Jul 7, 2026, 23:03Roxana González Mazarío: The Phenotype-Specific Cardiovascular Risks in AAV
-
Jul 7, 2026, 22:52Harry Spoelstra: LongC0VID Still has Zero Proven Treatments
-
Jul 7, 2026, 22:39Satya K. Morar: Acute Portal Vein Thrombosis as an Exceptionally Rare Complication of Liver Biopsy in CVID
-
Jul 7, 2026, 22:23Aravind Palraj: Antiphospholipid Syndrome is not Just ‘Start Warfarin and Follow INR’